Volume 18, Issue 1 (2023) | American Journal of Pharmacology and ToxicologyVolume 18, Issue 1 (2023) | American Journal of Pharmacology and Toxicology
https://thescipub.com/ajpt/issue/1414
Science PublicationsenScience Publications<![CDATA[Ribavirin Plus Therapy in Covid-19-A Single-Center Experience]]>
https://thescipub.com/ajpt/ajptsp.2023.1.7
American Journal of Pharmacology and Toxicology, Published online: 25 July 2023; doi:10.3844/ajptsp.2023.1.7COVID-19 infection has a similar clinical spectrum of disease presentation such as SARS and MERS in the past. These led to the assumption of the possibility to treat COVID-19 infection with antivirals...]]>Budha Oinam SinghGaurav ChikaraPrasan Kumar PandaYogesh Arvind BahurupiSarama SahaVenkatesh Srinivasa Paidoi:10.3844/ajptsp.2023.1.7American Journal of Pharmacology and Toxicology, Published online: 2023-07-25; | doi:10.3844/ajptsp.2023.1.72023-07-25Science Publications10.3844/ajptsp.2023.1.7https://thescipub.com/ajpt/ajptsp.2023.1.7<![CDATA[Optic Neuropathy: Characteristic Pathology for Identifying Drugs with Potential to Cause Mitochondrial Toxicity]]>
https://thescipub.com/ajpt/ajptsp.2023.9.16
American Journal of Pharmacology and Toxicology, Published online: 19 January 2024; doi:10.3844/ajptsp.2023.9.16Deleterious effects on mitochondria are known to be frequently caused by prescription drugs, however, there is no standard and specific testing by pharmaceutical companies on these effects on mitochon...]]>Connor DyerKatlyn DrokeUgne ZekonyteMariana Roscadoi:10.3844/ajptsp.2023.9.16American Journal of Pharmacology and Toxicology, Published online: 2024-01-19; | doi:10.3844/ajptsp.2023.9.162024-01-19Science Publications10.3844/ajptsp.2023.9.16https://thescipub.com/ajpt/ajptsp.2023.9.16